NL-OMON26385招募中不适用
Image guided treatment optimization with cetuximab for patients with metastatic colorectal cancer
VU University Medical Center (central site)UMC GroningenRadboud UMC0 个研究点目标入组 85 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 85
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Advanced colorectal adenocarcinoma
- •Subjects must have been treated according to standard care with palliative chemotherapy including a fluoropyrimidine (e.g. fluorouracil or capecitabine), irinotecan, and oxaliplatin or had contra-indications to treatment with these drugs.
排除标准
- •Previous exposure to an anti-EGFR therapy
- •Significant skin condition interfering with treatment
研究者
相似试验
进行中（未招募）
1 期
Image guided treatment optimalization with cetuximab for patients with metastatic colorectal cancer: IMPACT - CRCEUCTR2013-002023-41-NLVU University Medical Center151
已完成
2 期
Image guided treatment optimalization with cetuximab for patients with metastatic colorectal cancer: IMPACT - CRCmetastatic colorectal canceradvanced intestinal cancer10017991NL-OMON50209Vrije Universiteit Medisch Centrum151
终止
1 期
Image Guided Treatment Optimization With Cetuximab for Patients With Metastatic Colorectal CancerMetastatic Colorectal CancerNCT02117466Amsterdam UMC, location VUmc85
已完成
不适用
Treatment optimization of cetuximab in patients with metastatic colorectal cancer based on tumour uptake of 89Zr-labeled cetuximab assessed by PETmetastazised colorectal canceradvanced intestinal cancer10017991NL-OMON36409Vrije Universiteit Medisch Centrum38
进行中（未招募）
1 期
Treatment optimization of cetuximab in patients with metastatic colorectal cancer based on tumour uptake of 89Zr-labeled cetuximab assessed by PET - COLO CETUXadvanced colorectal cancerMedDRA version: 12.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerEUCTR2010-021943-41-NLVU Medical Center38